The Organ Shortage

Zoe Pollock, posting on Andrew Sullivan’s blog, links to a paper that notes the shortage of organs for transplant: 114,000 recipients on waiting lists, 14,000 donors per year.

The two most promising alternatives are xenotransplantation, the replacement of a human organ with an animal one, or engineering human organs from scratch.

Actually, no. As Sally Satel keeps pointing out, the most promising alternative is allowing financial rewards for organ donors. That’s especially relevant to kidneys, where the donor can go on to live a perfectly normal life and where the savings to the government from not needing to do dialysis are in the tens of thousands of dollars per patient per year. That would allow for hefty payments while leaving the program still a net cost-saver.

The bioethical dogma that forbids payment for donation is just another version of “Right-to-Life” absolutism: it caters to the scruples of those sitting comfortably in their offices, with no skin in the game, at real cost to the lives of actual people. (Just imagine if each opponent of payment had to explain, in person, to five potential recipients and their families that he, personally, made the decision to let the patient die, in order to prevent “commodification” and preserve the moral freedom of donors to make altruistic choices.)

Time to get past it.

[Cross-posted at The Reality-based Community]

Support Nonprofit Journalism

If you enjoyed this article, consider making a donation to help us produce more like it. The Washington Monthly was founded in 1969 to tell the stories of how government really works—and how to make it work better. Fifty years later, the need for incisive analysis and new, progressive policy ideas is clearer than ever. As a nonprofit, we rely on support from readers like you.

Yes, I’ll make a donation

Mark Kleiman

Mark Kleiman is a professor of public policy at the New York University Marron Institute.